Erik L. Regalado

Merck & Co., Inc., Rahway, NJ, USA (United States)

Papers

1

Total Citations

647

H-Index

1

About

Erik L. Regalado has pioneered the intersection of high-throughput experimentation and nanomole-scale synthesis, fundamentally reshaping how complex molecules are discovered and optimized. His landmark work, “Nanomole-scale high-throughput chemistry for the synthesis of complex molecules” (647 citations), introduced a miniaturized automation platform that enables rapid route scouting and reaction optimization using vanishingly small quantities of material—a breakthrough critical for drug discovery and natural product synthesis where precious intermediates are scarce. By demonstrating that sophisticated synthetic chemistry can be reliably performed at the nanomole scale, Regalado’s contributions have accelerated the pace of medicinal chemistry programs and expanded the toolkit for synthetic method development. His research integrates cutting-edge automation, analytical chemistry, and data science to deliver high-quality results under tight timelines, making him a leading voice in the movement toward more efficient, sustainable laboratory practices. Regalado’s work not only reduces waste and conserves scarce building blocks but also empowers chemists to explore broader chemical space with unprecedented speed. For students and researchers, his achievements exemplify how creative engineering of experimental workflows can unlock new frontiers in molecular synthesis.

Research Focus

Key Achievements

1
H-Index
1
Papers
647
Total Citations
647
Avg Citations/Paper
🏆 Most Cited Paper
Nanomole-scale high-throughput chemistry for the synthesis of complex molecules
647 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago